Jesús Frías

La Paz University Hospital - Servicio de Farmacología Clínica

Madrid

Spain

SCHOLARLY PAPERS

6

DOWNLOADS
Rank 10,343

SSRN RANKINGS

Top 10,343

in Total Papers Downloads

8,303

SSRN CITATIONS

4

CROSSREF CITATIONS

0

Scholarly Papers (6)

1.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Number of pages: 38 Posted: 27 May 2021
La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Instituto de Salud Carlos III- Laboratorio de Serología, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - Laboratorio de Serología, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, University Hospital 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica and Independent
Downloads 7,817 (1,546)
Citation 12

Abstract:

Loading...

VACCELERATE Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment

Number of pages: 21 Posted: 07 Apr 2022
University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), affiliation not provided to SSRN, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), affiliation not provided to SSRN, affiliation not provided to SSRN, European University Cyprus, European University Cyprus, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Antwerp - Vaccine and Infectious Disease Institute, affiliation not provided to SSRN, European University Cyprus, University of Cologne - Division of Infectious Diseases, affiliation not provided to SSRN, European University Cyprus, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Assistance Publique-Hôpitaux de Paris - Clinical Investigation Center (CIC 1417), affiliation not provided to SSRN, affiliation not provided to SSRN, La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, European University Cyprus, La Paz University Hospital - Servicio de Farmacología Clínica, affiliation not provided to SSRN, affiliation not provided to SSRN, Hacettepe University, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, affiliation not provided to SSRN, University of Bergen - Influenza Centre, affiliation not provided to SSRN, Vilnius University, University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), affiliation not provided to SSRN, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Karolinska Institutet - Division of Infectious Diseases, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN, Medical University of Vienna - Department of Clinical Pharmacology, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), European University Cyprus - School of Medicine and affiliation not provided to SSRN
Downloads 21 (930,524)
Citation 3

Abstract:

Loading...

SARS-CoV-2, registry, pandemic preparedness, clinical trial, volunteer, vaccination campaign, COVID-19, vaccination network

3.

Immunogenicity and Reactogenicity of a First Booster with NT162b2or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1)

Number of pages: 29 Posted: 02 Jun 2023
University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Hacettepe University - Department of Infectious Diseases, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Clinical Trials Centre Cologne (ZKS Koln), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University of Antwerp - Laboratory of Medical Microbiology (LMM), University of Antwerp - Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), University of Antwerp - Laboratory of Medical Microbiology (LMM), University of Antwerp - Laboratory of Medical Microbiology (LMM), University of Antwerp - Laboratory of Medical Microbiology (LMM), University of Antwerp - Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), Medical University of Vienna - Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna - Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna - Center for Medical Statistics, Informatics, and Intelligent Systems, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD)
Downloads 175 (302,642)
Citation 1

Abstract:

Loading...

SARS-CoV-2, vaccine, COVID-19, mRNA, elderly, immunisation

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

Number of pages: 82 Posted: 25 Mar 2022
Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Hospital Universitario Cruces, Hospital Clínic de Barcelona, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health, Carlos III Institute of Health, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology and Independent
Downloads 90 (505,249)

Abstract:

Loading...

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

Number of pages: 39 Posted: 21 Mar 2022
Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), affiliation not provided to SSRN, affiliation not provided to SSRN, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, affiliation not provided to SSRN, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Instituto de Salud Carlos III- Laboratorio de Serología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit and Independent
Downloads 48 (710,509)

Abstract:

Loading...

SARS-CoV-2, heterologous vaccination, Neutralisation, Variants, antibodies

5.

Immunogenicity, Reactogenicity and Safety of a Second Booster with BNT162b2 or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1-AGED Part B)

Number of pages: 42 Posted: 22 Dec 2023
University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Medical University of Vienna - Center for Medical Statistics, Informatics, and Intelligent Systems, Goethe University Frankfurt - University Hospital Frankfurt, University of Bergen - Haukeland University Hospital, La Paz University Hospital - Servicio de Farmacología Clínica, University of Córdoba, Hospital Universitari Germans Trias i Pujol, Biodonostia Health Research Institute, Department of Pneumology, Hannover Medical School, member of the German Centre for Lung Research (DZL), Vilnius University - Vilnius University Hospital Santaros Klinikos, Hacettepe University, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University of Cologne, University of Cologne, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University of Cologne, La Paz University Hospital - Servicio de Farmacología Clínica, University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin (UCD) - Centre for Experimental Pathogen Host Research (CEPHR), University of Antwerp - Laboratory of Medical Microbiology (LMM), University of Antwerp - Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), University of Antwerp - Laboratory of Medical Microbiology (LMM), University of Antwerp - Laboratory of Medical Microbiology, University of Antwerp - Laboratory of Medical Microbiology, University of Antwerp - Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), Medical University of Vienna - Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna - Center for Medical Statistics, Informatics, and Intelligent Systems, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD)
Downloads 105 (470,931)

Abstract:

Loading...

SARS-CoV-2, advanced age, fourth dose, booster vaccination, immunosenescence, variants of concern, anti-RBD IgG, neutralising antibodies

6.

Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS Study

Number of pages: 27 Posted: 01 Mar 2022
Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz - Department of Laboratory Medicine, Hospital Universitario La Paz, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Hospital Universitario La Paz, Hospital Universitario La Paz, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, La Paz University Hospital - Servicio de Farmacología Clínica, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ and Hospital Universitario La Paz
Downloads 47 (700,878)

Abstract:

Loading...

COVID-1, heterologous vaccination, haemostasis